Abstract
Extensive investigation into the molecular basis of iron overload disorders has provided new insights into the complexity of iron metabolism and related cellular pathways. The possible involvement of genes affecting iron homeostasis, including HFE, SLC40A1, HAMP and CYBRD1, was investigated in individuals who were referred for confirmation or exclusion of a diagnosis of haemochromatosis, but who tested negative or were heterozygous for the causative HFE mutation, C282Y. Denaturing high performance liquid chromatography analysis of these genes revealed a unique spectrum of mutations in the South African study population, including 67 unrelated patients and 70 population-matched controls. Two novel CYBRD1 gene mutations, R226H and IVS1-4C→G, were identified in 11% of South African Caucasian patient referrals. We identified a novel D270V mutation in the SLC40A1 gene in a Black South African female with iron overload. These mutations were absent in the control population. In Africans with iron overload not related to the HFE gene, the possible involvement of the SLC40A1 and CYBRD1 genes was demonstrated for the first time. This study confirms the genetic heterogeneity of haemochromatosis and highlights the significance of CYBRD1 mutations in relation to iron overload.
Similar content being viewed by others
References
Adams PC, Campion ML, Gandon G, Le Gall J-Y, David V, Jouanolle A-M (1997) Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families. Hepatology 26:986–990
Bacon BR, Sadiq SA (1997) Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 92:784–789
Beutler E, West C (1997) New diallelic markers in the HLA region of chromosome 6. Blood Cells Mol Dis 23:219–229
Borrego S, Saez ME, Ruiz A, Gimm O, Lopez-Alonso M, Antinolo G, Eng C (1999) Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 36:771–774
Bothwell TH, Charlton RW, Motulsky AG (1995) Hemochromatosis. In: Scriver CR, Scriver AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 7th edn. McGraw-Hill, New York, pp 2237–2269
Breathnach R, Chambon P (1981) Organisation and expression of eukaryotic split genes coding for proteins. Annu Rev Biochem 50:349–383
Caceres JF, Stamm S, Helfman DM, Krainer AR (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706–1709
Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15
Cambien F, Poirier O, Nicaud V, Herrmann SM, Mallet C, Ricard S, Behague I, Hallet V, Blanc H, Loukaci V, Thillet J, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L (1999) Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet 65:183–191
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES (1999) Characterisation of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231–238
Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev 3:285–298
Cazzola M, Cremonesi L, Papaioannou M, Soriani N, Kioumi A, Charalambidou A, Paroni R, Romtsou K, Levi S, Ferrari M, Arosio P, Christakis J (2002) Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br J Haematol 119:539–546
De Villiers JN, Hillermann R, Loubser L, Kotze MJ (1999) Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria. Hum Mol Genet 8:1517–1522
Devalia V, Carter K, Walker AP, Perkins SJ, Worwood M, May A, Dooley JS (2002) Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100:695–697
Douabin-Gicquel V, Soriano N, Ferran H, Wojcik F, Palierne E, Tamim S, Jovelin T, McKie AT, Le Gall JY, David V, Mosser J (2001) Identification of 96 single nucleotide polymorphisms in eight genes involved in iron metabolism: efficiency of bioinformatic extraction compared with a systematic sequencing approach. Hum Genet 109:393–401
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408
Fitze G, Schreiber M, Kuhlisch E, Schackert HK, Roesner D (1999) Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease. Am J Hum Genet 65:1469–1473
Gordeuk VR, Caleffi A, Corradini E, Ferrara F, Jones RA, Castro O, Onyekwere O, Kittles R, Pignatti E, Montosi G, Garuti C, Gangaidzo IT, Gomo ZAR, Moyo VM, Rouault TA, Macphail P, Pietrangelo A (2003) Iron overload in Africans and African-Americans and a common mutation in the SLC40A1 (ferroportin 1) gene. Blood Cell Mol Dis 31:299–304
Henz S, Reichen J, Liechti-Gallati S (1997) HLA-H gene mutations and haemochromatosis: the likely association of H63D with mild phenotype and the detection of S65C, a novel variant in exon 2. J Hepatol 26:57
Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C (2003) Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11a3) mutations. Blood 102:1904–1910
Höhler T, Leininger S, Schneider PM (1999) A new polymorphism in the human HFE gene. Immunogenetics 49:823–824
Jouanolle AM, Douabin-Gicquel V, Halimi C, Loreal O, Fergelot P, Delacour T, Lajarte-Thirouard AS de, Turlin B, Le Gall JY, Cadet E, Rochette J, David V, Brissot P (2003) Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J Hepatol 39:286–289
Kotze MJ, Villiers JNP de, Bouwens CSH, Warnich L, Zaahl MG, Merwe S van der, Oberkanins C (2004) Molecular diagnosis of hereditary hemochromatosis: application of a newly-developed reverse-hybridization assay in the South African population. Clin Genet 65:317–321
Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147–150
Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54
Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E (2001) A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and −2, and hepcidin. Blood Cells Mol Dis 27:783–802
McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, Simpson RJ (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:1755–1759
McKie AT, Latunde-Dada GO, Miret S, McGregor JA, Anderson GJ, Vulpe CD, Wrigglesworth JM, Simpson RJ (2002) Molecular evidence for the role of a ferric reductase in iron transport. Biochem Soc Trans 30:722–724
Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VLC, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJH (2003) Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 12:2241–2247
Milani MY, Kotze MJ (1999) Molecular diagnosis of hereditary haemochromatosis–identify an affected person and save a family. S Afr Med J 89:263–264
Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623
Mount S (1982) A catalogue of splice junction sequences. Nucleic Acids Res 10:459–472
Muro AF, Caputi M, Pariyarath R, Pagani F, Buratti E, Baralle FE (1999) Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol Cell Biol 19:2657–2671
Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98:8780–8785
Njajou OT, Vaessen N, Joosse M, Berghuis B, Dongen JW van, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, Duijn CM van, Heutink P (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213–214
Padgett R, Grabowski P, Konarska M, Seiler S, Sharp P (1986) Splicing of messenger RNA precursors. Annu Rev Biochem 55:1119–1150
Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811–7819
Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJH (2000) Uncommon mutations in the hemochromatosis gene. Genet Test 4:151–161
Powell LW, Jazwinska EC, Halliday JW (1994) Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. Saunders, London, pp 228–270
Rhodes D, Raha-Chowdhury R, Cox TM, Trowsdale J (1997) Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis. J Med Genet 34:761–764
Rivard SR, Lanzara C, Grimard D, Carella M, Simard H, Ficarella R, Simard R, D’Adamo AP, De Braekeleer M, Gasparini P (2003) Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family. Haematologica 88:824–826
Rochette J, Pointon JJ, Fisher CA, Perera G, Arambepola M, Arichchi DS, De Silva S, Vandwalle JL, Monti JP, Old JM, Merryweather-Clarke AT, Weatherall DJ, Robson KJ (1999) Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 64:1056–1062
Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, Cali A, De Gobbi M, Gasparini P, Camaschella C (2001) New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97:2555–2560
Roetto A, Merryweather-Clarke AT, Daraio F, Livesey K, Pointon JJ, Barbabietola G, Piga A, Mackie PH, Robson KJ, Camaschella C (2002) A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4. Blood 100:733–734
Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22
Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U (2002) The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 70:758–762
Sachot S, Moirand R, Jouanolle AM, Mosser J, Fergelot P, Deugnier Y, Brissot P, Gall JY le, David V (2001) Low penetrant hemochromatosis phenotype in eight families: no evidence of modifiers in the MHC region. Blood Cells Mol Dis 27:518–529
Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW, Subramaniam VN (2002) Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100:692–694
Worwood M, Shearman JD, Wallace DF, Dooley JS, Merryweather-Clarke AT, Pointon JJ, Rosenberg WMC, Bowen DJ, Burnett AK, Jackson HA, Lawless S, Raha-Chowdhury R, Partridge J, Williams R, Bomford A, Walker AP, Robson KJH (1997) A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 41:841–844
Yang Z, Zhu T, Ma G, Yin H, Qian W, Zhang F, Cao K, Ma W (2001) Apolipoprotein E polymorphism in the early onset of coronary heart disease. Chin Med J 114:983–985
Zaahl MG, Robson KJH, Warnich L, Kotze MJ (2004) Differential expression of the 5′-(GT)n repeat in the SLC11A1 gene: opposite allelic effect in the presence of the −237C→T polymorphism. Blood Cells Mol Dis 33:45–50
Zahler AM, Neugebauer KM, Lane WS, Roth MB (1993) Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219–222
Acknowledgements
This work was supported by the South African Medical Research Council, the Universities of Stellenbosch, South Africa and Oxford, United Kingdom, the Medical Research Council and the British Association of Commonwealth scholarships. This work was also supported by EC contract QLRT 1999-02237.
Author information
Authors and Affiliations
Corresponding author
Additional information
Nucleotide sequence data reported are available in the Genbank database under the assession numbers AJ604512, AJ609539, AJ616848, AJ616847, AJ609540, AJ715523, AJ715524 and AJ715525.
Rights and permissions
About this article
Cite this article
Zaahl, M.G., Merryweather-Clarke, A.T., Kotze, M.J. et al. Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload. Hum Genet 115, 409–417 (2004). https://doi.org/10.1007/s00439-004-1166-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-004-1166-y